Yuval Cohen

2017

In 2017, Yuval Cohen earned a total compensation of $3.2M as Chief Executive Officer at Corbus Pharmaceuticals Holdings, a 58% increase compared to previous year.

Compensation breakdown

Bonus$267,383
Option Awards$2,511,886
Salary$463,000
Total$3,242,269

Cohen received $2.5M in option awards, accounting for 77% of the total pay in 2017.

Cohen also received $267.4K in bonus and $463K in salary.

Rankings

In 2017, Yuval Cohen's compensation ranked 3,298th out of 14,666 executives tracked by ExecPay. In other words, Cohen earned more than 77.5% of executives.

ClassificationRankingPercentile
All
3,298
out of 14,666
78th
Division
Manufacturing
1,132
out of 5,768
80th
Major group
Chemicals And Allied Products
310
out of 2,074
85th
Industry group
Drugs
238
out of 1,730
86th
Industry
Pharmaceutical Preparations
188
out of 1,329
86th
Source: SEC filing on April 13, 2018.

Cohen's colleagues

We found three more compensation records of executives who worked with Yuval Cohen at Corbus Pharmaceuticals Holdings in 2017.

2017

Barbara White

Corbus Pharmaceuticals Holdings

Chief Medical Officer

2017

Mark Tepper

Corbus Pharmaceuticals Holdings

Chief Scientific Officer

2017

Sean Moran

Corbus Pharmaceuticals Holdings

Chief Financial Officer

In-depth

You may also like